Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCHLine

Items in this list may be obtained from the sources cited. Contact information reflects the most current data about the source that has been provided to the MCH Digital Library.

Displaying records 1 through 20 (108 total).

American Council for Drug Education. n.d.. Drugs may harm your unborn baby: Only take drugs your doctor prescribes. Washington, DC: American Council for Drug Education, 1 poster (17 x 22 inches).

Barzel R, Holt K, Kolo S. 2026. Opioids and pregnant women: Information for oral health professionals(updated ed.). Washington, DC: National Maternal and Child Oral Health Resource Center, 4 pp.

Annotation: This paper provides information on pain management, including opioid use, for pregnant women during dental procedures. Pharmacological considerations, including indications, contraindications, and special considerations for pharmacological agents are presented. Neonatal opioid withdrawal syndrome is discussed, and guidelines for prescribing opioids are presented. Also included is information about prescription drug monitoring programs and managing acute dental pain, as well as recommendations for discharging women with prescriptions. [Funded by the Maternal and Child Health Bureau]

Keywords: Drug addiction, Guidelines, Narcotics, Neonatal abstinence syndrome, Oral health, Pain relieving drugs, Pregnant women, Prescription drugs

U.S. Food and Drug Administration, Center for Drug Evaluation and Research. 2025. Ingestible fluoride drug products: A scientific evaluation of use, benefits, and risks in the pediatric population. Silver Spring, MD: U.S. Food and Drug Administration, Center for Drug Evaluation and Research, 27 pp.

Annotation: This report presents benefit/risk considerations related to the use of ingestible fluoride drug products in children. It includes a brief history of prescription drug products containing fluoride that have not been approved by the U.S. Food and Drug Administration (FDA) and the context in which ingestible fluoride drug products are currently being discussed. It presents an overview of sources of ingested fluoride. It also covers FDA’s analysis of key data, including an overview of recent use trends, a review of potential benefits from ingestible fluoride drug products, and a review of potential risks from such products.

Keywords: Dental caries, Fluoride, Oral health, Prescription drugs, Prevention, Research

Wisconsin Department of Health Services. 2025. Oral health antibiotic toolkit. Madison, WI: Wisconsin Department of Health Services, 20 pp.

Annotation: This report focuses on antibiotic use in dentistry and on how to practice antibiotic stewardship to prevention overprescription, which can lead to antibiotic resistance and avoidable antibiotic-related side effects. Topics include antibiotic resistance, guidance and recommendations on antiobotics prescribing in dentistry, penicillin allergy, and supporting safe antiobiotic prescribing.

Keywords: Allergy, Antibiotics, Oral health, Penicillins, Prescription drugs, Side effects

American College of Obstetricians and Gynecologists (ACOG). 2023. Treatment and management of mental health conditions during pregnancy and postpartum. Washington, DC: American College of Obstetricians and Gynecologists,

Barzel R, Holt K. 2022. Opioids and children and adolescents: Information for oral health professionals. Washington, DC: National Maternal and Child Oral Health Resource Center, 6 pp.

Annotation: This document provides guidance on opioids for oral health professionals. It includes information about assessing children and adolescents, drugs to recommend before prescribing opioids, prescribing opioids with caution and being aware of the potential for misuse or abuse, and understanding laws, policies, and recommendations. The document also discusses providing post-operative instructions and creating a safe, friendly environment. Information about prescription-drug-monitoring programs and managing acute oral pain are included, along with tips for dentists to share with parents and an overview of research. [Funded by the Maternal and Child Health Bureau]

Keywords: Adolescent health, Child health, Drug abuse, Narcotics, Oral health, Pain, Prescription drugs, Prevention

Singh AD, and Association of State and Territorial Dental Directors, Dental Public Health Policy Committee . 2021. Policy statement: Reducing opioid prescribing by oral health professionals. Reno, NV: Association of State and Territorial Dental Directors, 13 pp.

Annotation: This statement provides data related to reducing opioid prescribing by oral health professionals and highlights policies and strategies, including the introduction, adoption, and promotion of prescribing guidelines by the American Dental Association and the Centers for Disease Control and Prevention. Also discussed are state requirements for dentist participation in prescription drug monitoring programs, continuing education for oral health professionals related to pain management, and inclusion of pain-management approaches in dental education. The statement also highlights how state oral health programs have identified and engaged in promising and effective approaches related to opioid prescription practices.

Keywords: Dental education, Health policy, Narcotics, Oral health, Pain management, Prescription drugs, Public policy, State programs

Henderson JT, Vesco KK, Senger CA, Thomas RG, Redmond N. 2021. Aspirin use to prevent preeclampsia and related morbidity and mortality: Updated systematic review for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality, 157 pp. (Evidence synthesis; no. 205; AHRQ publication; no. 21-05274-EF-1)

Annotation: This systematic review was conducted to support the United States Preventive Services Task Force in updating its 2014 recommendation on daily low dose aspirin use during pregnancy for individuals at increased risk for preeclampsia. The report reviewed updated evidence on the effectiveness and potential harms of daily aspirin use during pregnancy to prevent morbidity and mortality associated with preeclampsia. Data sources included MEDLINE, PubMed, Embase, and the Cochrane Collaboration Registry of Controlled Trials; results were limited to studies published between January 2013 and July 2019. The reviewed studies showed that daily aspirin use in pregnancy for individuals at increased risk for preeclampsia consistently led to beneficial effects on perinatal mortality, preterm birth, fetal growth restriction, and preeclampsia diagnosis.

Keywords: Pregnant women, Drugs, Evidence based medicine, High risk groups, Literature reviews, Maternal health, Perinatal care, Preeclampsia, Pregnancy, Pregnancy complications, Pregnancy outcomes, Preventive health services

Association of Maternal and Child Health Programs . 2021. Perinatal cannabis use in the era of increasing legalization: Considerations for state MCH programs. Washington, DC: Association of Maternal and Child Health Programs , 28 pp.

Annotation: This issue brief is a call to action for maternal and child health (MCH) professionals to be leaders in designing and implementing public health approaches to minimize the potential harms of perinatal cannabis (marijuana) use. The brief describes trends in Cannabis use among pregnant people, addresses the changing policy landscape, and discusses the racial implications of criminalizing the use of drugs among pregnant people and mothers. State MCH program approaches to help prevent eprinatal cannabis use are included.

Keywords: Cannabis, Illicit drugs, Marijuana, Maternal health, Models, Perinatal care, Pregnancy, Prevention, Substance use

American Dental Association Health Policy Institute. 2018. Opioid prescribing by dentists. Chicago, IL: American Dental Association Health Policy Institute, 1 p.

Annotation: This infographic provides information about trends in the percentages of opioids prescribed by dentists to individuals with private dental insurance between 2010 and 2015. Total percentages are provided, as well as percentages by age group. Information about days’ supply and quantities of pills prescribed by dentists to individuals with private insurance for 2010–2015 is also presented.

Keywords: , Narcotics, Oral health, Oral health care, Prescription Drugs, Statistical data, Trends

Oregon Pregnancy and Opioids Workgroup. 2018. Oregon Pregnancy and Opioids Workgroup recommendations. Salem, OR: Oregon Health Authority, Public Health Division, 27 pp.

U.S. Substance Abuse and Mental Health Services Administration. 2018. Medicaid coverage of medication-assisted treatment for alcohol and opioid use disorders and of medication for the reversal of opioid overdose. Rockville, MD: U.S. Substance Abuse and Mental Health Services Administration, 113 pp.

Annotation: This report presents summary information on Medicaid coverage and financing of medications to treat alcohol and opioid use disorders (MAT). It discusses issues including prior authorization, innovative approaches to financing and delivering MAT, state considerations for covering MAT (including efficacy, costs, regulations, and policies), and innovative models and best practices.

Keywords: Alcohol dependence, Drugs, Health care financing, Medicaid, Opiates, Substance abuse treatment

Before the First Tooth. [2017]. Rx: Bring this with you to your next appointment [Prescription referral form]. Portland, ME: Before the First Tooth, 1 p.

Annotation: This referral form for health professionals to fill out provides information that pregnant women can bring to their next dental appointment. The form includes blanks to fill in the woman’s name, date of birth, estimated delivery date, and known allergies and boxes to check indicating what types of oral health care are acceptable for the woman to receive and whether there are any precautions to note. Also included are boxes to check indicating pain medications and antibiotics that are safe for the woman. [Funded by the Maternal and Child Health Bureau]

Keywords: Antibiotics, Drugs, Oral health, Oral health care, Pregnant women

Clevenger AA. 2017. Overdose poisoning deaths to children in Virginia, 2009-2013. Richmond, VA: Virginia Department of Health, Office of the Chief Medical Examiner, 57 pp.

Annotation: This report presents findings, conclusions, and recommendations from case reviews of overdose poison deaths among infants, children, and adolescents up to age 17 in Virginia for the five year period between 2009 and 2013. Topics include how overdose is impacting infants and children and their families in Virginia, which children are at risk, where are they at risk, how are they at risk, and what can be done to further promote health and safety in their lives. [Funded in part by the Maternal and Child Health Bureau]

Keywords: Adolescents, Case studies, Child death review, Child safety, Children, Health promotion, High risk groups, Household safety, Infants, Injury prevention, Opiates, Poisoning, Prescription drugs, Virginia

Oregon Health Authority, Oral Health Unit. 2017. Opioid prescribing guidelines for dentists. Portland, OR: Oregon Health Authority, Oral Health Unit, 1 p.

Annotation: This document for dentists provides guidelines on prescribing opioids. Appropriate dosages, types of medication to prescribe, prescribing refills, using guidelines for pain management, and ensuring that patients know how to secure medication and dispose of leftover medication are discussed. Alternatives to prescribing opioids are presented. Information is included on how to obtain the document in large print, Braille, non- English languages, or other formats.

Keywords: Guidelines, Medications, Opiates, Pain, Non English language materials, Prescription drugs

Children's Safety Network. 2016. Medication abuse prevention: 2016 resource guide. Waltham, MA: Children's Safety Network, 19 pp.

Annotation: This guide describes organizations, policy and legislation, prevention programs, publications, and webinars focused on prescription drug overdose prevention among youth and young adults. Contents include descriptions of reports, guides, toolkits, campaigns, website, iinitiatives, and research studies. Each item includes a short description and a link to the resource itself. Information about child safety and neonatal abstinence syndrome are included. [Funded by the Maternal and Child Health Bureau]

Keywords: Adolescents, Children, Drug effects, Infants, Legislation, Multimedia, Neonatal abstinence syndrome, Policy development, Prescription drugs, Resource materials, Resources for professionals, Safety, Substance abuse prevention, Substance abuse prevention programs, Young adults

Rudd RA, Seth P, Felicita D, Scholl L. 2016. Increases in drug and opioid-involved overdose deaths: United States, 2010–2015. Morbidity and Mortality Weekly Report 65(50–51):1445–1452,

Annotation: This report examines overall drug overdose death rates during 2010-2015 and opioid overdose death rates during 2014–2015 by subcategories (natural/semisynthetic opioids, methadone, heroin, and synthetic opioids other than methadone). Rates are stratified by demographics, region, and by 28 states with high quality reporting on death certificates of specific drugs involved in overdose deaths. Implications for public health practice are included.

Keywords: Chronic pain, Collaboration, Drug addiction, Heroin, Illicit drugs, Methadone, Mortality rates, Opiates, Prescription drugs, Substance abuse prevention, Substance abuse treatment services

U.S. Government Accountability Office. 2015. Prenatal drug use and newborn health: Federal efforts need better planning and coordination. Washington, DC: U.S. Government Accountability Office,

Annotation: This report provides information on how federal agencies have addressed opioid use by pregnant women and neonatal abstinence syndrome (NAS). Topics include federally funded research, federal programs, and other federal agency efforts related to prenatal opioid use or NAS; gaps identified by federal agency officials and experts in efforts to address prenatal opioid use or NAS; and how federal efforts to address prenatal opioid use or NAS are planned and coordinated.

Keywords: Analgesic drugs, Federal agencies, Infant health, Newborn infants, Prenatal influences, Prevention, Program coordination, Program development, Program planning, Referrals, Research, Screening, Substance use

Fobbs E, Grady K, Chiang RJ, Zavacky F. 2015. State school health policy matrix 2.0. [Atlanta, GA]: National Association of Chronic Disease Directors; [Washington, DC]: National Association of State Boards of Education; [Reston, VA]: Society of Health and Physical Educators, 31 pp.

Annotation: This guide outlines state-level school health policies related to competitive foods and beverages, physical education and physical activity, and administration of medication in the school environment. Contents include a direct link to the policy and information about which political entity or agency adopted the policy or issued guidance.

Keywords: Drugs, Health policy, Physical activity, Physical education, Policy development, School food services, Schools, Service delivery systems

Centers for Disease Control and Prevention. 2014-. Treating for two: Safer medication use in pregnancy. Atlanta, GA: Centers for Disease Control and Prevention, 1 v.

Annotation: This website provides resources from an initiative to prevent birth defects and improve the health of mothers by identifying alternatives for treatment of common conditions during pregnancy and during the childbearing years. Contents include information and resources for parents and clinicians on medication use before and during pregnancy, and while breastfeeding. Topics include planning for pregnancy, the effects of medications during pregnancy, lists of safe medications during pregnancy, discussing current medications, accidental exposure, and a peer-reviewed database of drugs to which women who are breastfeeding may be exposed.

Keywords: Adverse effects, Breastfeeding, Drug therapy, Drugs, Federal initiatives, Pregnancy, Pregnant women, Self medication
    Next Page »

The MCH Library is one of six special collections at Georgetown University, the nation's oldest Jesuit institution of higher education. The library is supported through foundation, private, university, state, and federal funding. This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by Georgetown University or the U.S. Government. Note: web pages whose development was supported by federal government grants are being reviewed to comply with applicable Executive Orders.